UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053564
Receipt number R000061120
Scientific Title Randomised crossover controlled trial on the effect of underwater recumbent ergometer exercise on renal artery blood flow in people with diabetes mellitus.
Date of disclosure of the study information 2024/04/01
Last modified on 2024/02/07 13:20:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomised crossover controlled trial on the effect of underwater recumbent ergometer exercise on renal artery blood flow in people with diabetes mellitus.

Acronym

The study of the effect of underwater recumbent ergometer exercise performed by people with diabetes mellitus on renal arterial blood flow.

Scientific Title

Randomised crossover controlled trial on the effect of underwater recumbent ergometer exercise on renal artery blood flow in people with diabetes mellitus.

Scientific Title:Acronym

Randomised crossover controlled trial on the effect of underwater recumbent ergometer exercise on renal artery blood flow in people with diabetes mellitus.

Region

Japan


Condition

Condition

Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of underwater recumbent ergometer exercise on renal artery blood flow in people with diabetes mellitus.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mean blood flow velocity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Underwater recumbent ergometer exercise for 15min

Interventions/Control_2

recumbent ergometer exercise on land for 15min

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Patients with diabetes whose age is between 40 and 65 years at the time written consent is obtained.
(2) Have no exercise restrictions as directed by their doctor
(3) Patients who have given their free written consent to participate in the study

Key exclusion criteria

(1) Those with lower limb bone and joint disease or / and ischemic heart disease or cardiopulmonary impairment, which makes it difficult to perform the pedaling exercises used in this study
(2) Persons with an HbA1c of 8.0% or more or / and a fasting blood glucose level of 250 mg/dL or more or a positive urine ketone on a recent blood test in the last month
(3) Post renal transplantation or those whose renal function is in the obvious nephropathy phase to dialysis phase
(4) Persons presenting with autonomic neuropathy
(5) Persons presenting with advanced retinopathy beyond simple retinopathy
(6) Persons with unstable blood pressure control
(7) Persons with complications of psychiatric or cognitive disorders requiring treatment
(8) Pregnant women
(9) Persons with a history of major surgery within 180 days prior to obtaining consent
(10) Persons with acute generalized infectious diseases requiring treatment
(11) Persons with a BMI of 25.0 kg/m2 or more
(12) Persons who smoke
(13) Persons who have an allergic reaction to zinc (synthetic acrylic fiber) used for the adhesive surface of ECG electrodes
(14) Other patients considered unsuitable by the person in responsible charge of the study

Target sample size

14


Research contact person

Name of lead principal investigator

1st name Hisafumi
Middle name
Last name YASUDA

Organization

Kobe University Graduate School of Health Sciences

Division name

Department of Public Health

Zip code

6540142

Address

7-10-2, Suma, Kobe, Hyogo, JAPAN

TEL

078-792-2555

Email

yasuda@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Kumiko
Middle name
Last name ONO

Organization

Kobe University Graduate School of Health Sciences

Division name

Department of Public Health

Zip code

6540142

Address

7-10-2, Tomogaoka, Suma, Kobe, Hyogo, JAPAN

TEL

078-792-2555

Homepage URL


Email

onoku@tiger.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Graduate School of Health Sciences

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital, intervention research ethical review board

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, JAPAN

Tel

078-382-6669

Email

kainyu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 02 Month 07 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 07 Day

Last modified on

2024 Year 02 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061120


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name